Pfizer/BioNTech already has full authorization in Switzerland, Australia and New Zealand, Saudi Arabia an Brazil. Pfizer/BioNTech made application for full app

Pfizer/BioNTech already has full authorization in Switzerland, Australia and New Zealand, Saudi Arabia an Brazil. Pfizer/BioNTech made application for full approval in the US and the goal is January 2022. Phase III trial formally ends early next year. The emergency authorization has provided huge amount of extra data outside ongoing Phase III trial.